MENLO PARK, Calif., Sept. 2, 2026 /PRNewswire/ — BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the Wells Fargo 21^st Annual Healthcare Conference.

Management will participate in a fireside chat from 2:15pm to 2:50pm Eastern Time on Wednesday, September 9, 2026.

A live and archived webcast will be available on the “Events & Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company’s proprietary single-molecule next-generation sequencing (smNGS) platform is the only multiplex technology that can detect and precisely quantify genetic targets at the physical limit of detection, down to the single DNA molecule. Enabled by Quantitative Counting Templates™ (QCTs™), the platform quantifies disease-related DNA fragments with single base-pair resolution, providing absolute quantification. For more information, visit www.billiontoone.com.

Investor Contact
ir@billiontoone.com

Media Contact
rachel@fordhutmanmedia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/billiontoone-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference-302868082.html

SOURCE BillionToOne